Log In
Print
BCIQ
Print
Print this Print this
 

Nplate, Romiplate, romiplostim

Also known as: formerly AMG 531

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionRecombinant fusion protein containing a pair of thrombopoietin (TPO) receptor-binding domains
Molecular Target Thrombopoietin (TPO) receptor (CD110) (Mpl)
Mechanism of ActionThrombopoietin (TPO) receptor (CD110) (Mpl) agonist
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.9M

$20.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today